LINDA M SUTTON
- Type
- Physician · Allopathic & Osteopathic Physicians / Internal Medicine / Medical Oncology
- Where
- ROXBORO, NC
- NPI
- 1366409575
- Received
- $9,893 in 43 records, 2019 to 2025 ($8,003 general, $1,890 research)
- As principal investigator
- $24,613 of research payments to others in 2 records
- Source
- CMS Open Payments search ↗
By year
| Program year | Kind | Records | Amount |
|---|---|---|---|
| 2025 | General payment | 7 | $154 |
| 2024 | General payment | 7 | $146 |
| 2024 | Research payment | 2 | $1,560 |
| 2023 | General payment | 9 | $5,860 |
| 2023 | Research payment | 1 | $330 |
| 2022 | General payment | 5 | $1,509 |
| 2021 | General payment | 7 | $183 |
| 2019 | General payment | 5 | $149 |
By company
| Company | Records | Amount | Years |
|---|---|---|---|
| PFIZER INC. | 8 | $6,412 | 2023–2025 |
| AstraZeneca Pharmaceuticals LP | 5 | $1,579 | 2019–2022 |
| Gilead Sciences, Inc. | 2 | $1,291 | 2021–2023 |
| Janssen Biotech, Inc. | 7 | $192 | 2021–2023 |
| Merck Sharp & Dohme LLC | 5 | $109 | 2022–2025 |
| BeOne Medicines USA, Inc. | 2 | $49 | 2025 |
| SOBI, INC | 2 | $36 | 2025 |
| Genmab U.S., Inc. | 1 | $30 | 2023 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $28 | 2025 |
| GENZYME CORPORATION | 2 | $26 | 2019–2024 |
| Daiichi Sankyo Inc. | 1 | $23 | 2024 |
| Eisai Inc. | 1 | $19 | 2024 |
| Spectrum Pharmaceuticals Inc. | 1 | $19 | 2024 |
| Celgene Corporation | 1 | $17 | 2022 |
| EMD Serono, Inc. | 1 | $15 | 2019 |
| Kite Pharma, Inc. | 1 | $14 | 2021 |
| Janssen Pharmaceuticals, Inc | 1 | $13 | 2022 |
| ARRAY BIOPHARMA INC | 1 | $13 | 2023 |
By nature of payment
| Nature | Records | Amount |
|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a v | 3 | $5,921 |
| Research payment | 3 | $1,890 |
| Consulting Fee | 1 | $1,280 |
| Food and Beverage | 34 | $690 |
| Education | 2 | $110 |
Records
| Date | Company | Amount | Nature | Form | Product | Study | Year |
|---|---|---|---|---|---|---|---|
| 2025-12-17 | BeOne Medicines USA, Inc. | $29 | Food and Beverage | In-kind items and services | BRUKINSA Drug, Oncology | 2025 | |
| 2025-10-01 | PFIZER INC. | $21 | Food and Beverage | In-kind items and services | ELREXFIO Drug, ONCOLOGY | 2025 | |
| 2025-09-17 | BeOne Medicines USA, Inc. | $19 | Food and Beverage | In-kind items and services | BRUKINSA Drug, Oncology | 2025 | |
| 2025-08-13 | SOBI, INC | $17 | Food and Beverage | In-kind items and services | Vonjo Drug, Hematology/Oncology | 2025 | |
| 2025-07-02 | Takeda Pharmaceuticals U.S.A., Inc. | $28 | Food and Beverage | In-kind items and services | FRUZAQLA Drug, ONCOLOGY | 2025 | |
| 2025-02-04 | Merck Sharp & Dohme LLC | $17 | Food and Beverage | In-kind items and services | KEYTRUDA Biological, ONCOLOGY | 2025 | |
| 2025-01-07 | SOBI, INC | $19 | Food and Beverage | In-kind items and services | Vonjo Drug, Hematology/Oncology | 2025 | |
| 2024-10-04 | Merck Sharp & Dohme LLC | $29 | Food and Beverage | In-kind items and services | KEYTRUDA Biological, ONCOLOGY | 2024 | |
| 2024-07-17 | Merck Sharp & Dohme LLC | $20 | Food and Beverage | In-kind items and services | KEYTRUDA Biological, ONCOLOGY | 2024 | |
| 2024-06-14 | Spectrum Pharmaceuticals Inc. | $19 | Food and Beverage | In-kind items and services | ROLVEDON Drug, Oncology | 2024 | |
| 2024-06-10 | GENZYME CORPORATION | $14 | Food and Beverage | In-kind items and services | SARCLISA Biological, Oncology | 2024 | |
| 2024-04-16 | Eisai Inc. | $19 | Food and Beverage | In-kind items and services | Lenvima Drug, Oncology | 2024 | |
| 2024-03-05 | PFIZER INC. | $620 | Research payment | In-kind items and services | NO PRODUCT CLINICAL PUBLICATION PROGRAM | 2024 | |
| 2024-02-29 | PFIZER INC. | $940 | Research payment | In-kind items and services | NO PRODUCT CLINICAL PUBLICATION PROGRAM | 2024 | |
| 2024-02-21 | Daiichi Sankyo Inc. | $23 | Food and Beverage | In-kind items and services | Enhertu Drug, ONCOLOGY | 2024 | |
| 2024-01-10 | Merck Sharp & Dohme LLC | $19 | Food and Beverage | In-kind items and services | KEYTRUDA Biological, ONCOLOGY | 2024 | |
| 2023-11-29 | PFIZER INC. | $330 | Research payment | In-kind items and services | NON PRODUCT CLINICAL PUBLICATION PROGRAM | 2023 | |
| 2023-11-02 | Genmab U.S., Inc. | $30 | Food and Beverage | In-kind items and services | Tivdak Drug, Oncology | 2023 | |
| 2023-08-16 | PFIZER INC. | $14 | Food and Beverage | In-kind items and services | INLYTA Drug, ONCOLOGY | 2023 | |
| 2023-07-27 | Janssen Biotech, Inc. | $20 | Food and Beverage | In-kind items and services | IMBRUVICA Drug, Oncology | 2023 | |
| 2023-07-19 | Janssen Biotech, Inc. | $16 | Food and Beverage | In-kind items and services | DARZALEX Biological, Oncology | 2023 | |
| 2023-06-23 | PFIZER INC. | $780 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | In-kind items and services | 2023 | ||
| 2023-05-03 | ARRAY BIOPHARMA INC | $13 | Food and Beverage | In-kind items and services | LORBRENA Drug, ONCOLOGY | 2023 | |
| 2023-03-16 | PFIZER INC. | $5 | Food and Beverage | In-kind items and services | XTANDI Drug, ONCOLOGY | 2023 | |
| 2023-03-03 | Gilead Sciences, Inc. | $1,280 | Consulting Fee | Cash or cash equivalent | 2023 | ||
| 2023-02-01 | PFIZER INC. | $3,700 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | In-kind items and services | 2023 | ||
| 2022-12-14 | Janssen Biotech, Inc. | $15 | Food and Beverage | In-kind items and services | ERLEADA Drug, Oncology | 2022 | |
| 2022-06-01 | AstraZeneca Pharmaceuticals LP | $1,441 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | 2022 | ||
| 2022-03-16 | Celgene Corporation | $17 | Food and Beverage | Cash or cash equivalent | Pomalyst Drug, Hematology | 2022 | |
| 2022-02-09 | Janssen Pharmaceuticals, Inc | $13 | Food and Beverage | In-kind items and services | XARELTO Drug, Cardiovascular & Metabolism | 2022 | |
| 2022-01-05 | Merck Sharp & Dohme LLC | $22 | Food and Beverage | In-kind items and services | KEYTRUDA Biological, ONCOLOGY | 2022 | |
| 2021-10-25 | Janssen Biotech, Inc. | $14 | Food and Beverage | In-kind items and services | ERLEADA Drug, Oncology | 2021 | |
| 2021-09-27 | Janssen Biotech, Inc. | $13 | Food and Beverage | In-kind items and services | ERLEADA Drug, Oncology | 2021 | |
| 2021-09-17 | AstraZeneca Pharmaceuticals LP | $16 | Food and Beverage | In-kind items and services | CALQUENCE Drug, Oncology | 2021 | |
| 2021-09-06 | Janssen Biotech, Inc. | $99 | Education | In-kind items and services | IMBRUVICA Drug, Oncology | 2021 | |
| 2021-08-30 | Janssen Biotech, Inc. | $13 | Food and Beverage | In-kind items and services | ERLEADA Drug, Oncology | 2021 | |
| 2021-06-01 | Gilead Sciences, Inc. | $11 | Education | In-kind items and services | 2021 | ||
| 2021-03-11 | Kite Pharma, Inc. | $14 | Food and Beverage | In-kind items and services | 2021 | ||
| 2019-10-03 | EMD Serono, Inc. | $15 | Food and Beverage | In-kind items and services | Bavencio Biological, Oncology | 2019 | |
| 2019-08-28 | GENZYME CORPORATION | $12 | Food and Beverage | In-kind items and services | TUMOR LYSIS SYNDROME - DISEASE Drug | 2019 | |
| 2019-05-22 | AstraZeneca Pharmaceuticals LP | $17 | Food and Beverage | In-kind items and services | CALQUENCE Drug, Oncology | 2019 | |
| 2019-03-24 | AstraZeneca Pharmaceuticals LP | $54 | Food and Beverage | In-kind items and services | 2019 | ||
| 2019-01-25 | AstraZeneca Pharmaceuticals LP | $49 | Food and Beverage | In-kind items and services | 2019 |
Research payments naming this person as principal investigator
| Date | Company | Paid to | Amount | Study | Year |
|---|---|---|---|---|---|
| 2023-03-09 | Incyte Corporation | DUKE UNIVERSITY MEDICAL CENTER | $19,075 | PROSPECTIVE, LONGITUDINAL, NON INTERVENTIONAL STUDY OF DISEASE BURDEN AND TREATMENT OF PATIENTS WITH LOW RISK MYELOFIBRO | 2023 |
| 2021-11-23 | Incyte Corporation | Duke University | $5,537 | PROSPECTIVE, LONGITUDINAL, NON INTERVENTIONAL STUDY OF DISEASE BURDEN AND TREATMENT OF PATIENTS WITH LOW RISK MYELOFIBRO | 2021 |
CMS Open Payments: payments and transfers of value that drug and medical device makers and group purchasing organizations report to Medicare, program years 2019 on, as published by CMS (general, research and ownership records; refreshed by CMS each June and January). Links to other records on this site are by name (and state) only.
The area Census
County outline, the place (blue), the tract (orange) and the ZIP center (dot).
In Roxboro, NC, county Person County, NC, state North Carolina; placed by its city name.
| Measure | Place (city or town) Roxboro, NC | County Person County, NC | State North Carolina |
|---|---|---|---|
| Population B01003 | 8,182 | 39,542 | 10,730,404 |
| Population, 2020 census P1 | 8,134 | 39,097 | 10,439,388 |
| Median age B01002 | 45.3 | 44.2 | 39.1 |
| Under 18 B01001 | 20.2% | 20.6% | 21.8% |
| 65 and over B01001 | 22.3% | 21.3% | 17.2% |
| Households B11001 | 3,548 | 16,063 | 4,282,345 |
| Foreign born B05002 | 5.2% | 3.1% | 9.1% |
| Median household income B19013 | $36,553 | $63,300 | $72,388 |
| Median family income B19113 | $47,826 | $80,992 | $90,290 |
| Per capita income B19301 | $28,480 | $37,635 | $41,385 |
| Poverty rate B17001 | 33.3% | 17.5% | 13.0% |
| Unemployment rate B23025 | 13.5% | 5.6% | 4.7% |
| Civilian labor force B23025 | 3,644 | 19,614 | 5,336,863 |
| Mean commute (minutes) B08013 | 26.1 | 30.9 | 25.1 |
| Bachelor's degree or higher B15003 | 14.1% | 19.3% | 35.7% |
| Housing units B25001 | 4,003 | 18,584 | 4,895,668 |
| Owner-occupied B25003 | 50.7% | 77.3% | 66.6% |
| Renters B25003 | 49.3% | 22.7% | 33.4% |
| Median home value B25077 | $157,700 | $213,900 | $288,900 |
| Median gross rent B25064 | $860 | $864 | $1,228 |
| White, not Hispanic B03002 | 44.8% | 64.2% | 60.0% |
| Black B03002 | 39.0% | 25.8% | 20.0% |
| Hispanic or Latino B03002 | 7.8% | 6.3% | 11.3% |
| Asian B03002 | 0.5% | 0.1% | 3.3% |
| American Indian and Alaska Native B03002 | 0.0% | 0.1% | 0.8% |
Data: IPUMS NHGIS (ACS 2020-2024 and the 2020 census); each figure links to its table for that area at data.census.gov. Records are placed by ZIP code and city name, not street address. More: everything FURP has in Roxboro, NC.
Comments